# Beijing OriginPoly Bio-Tec Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-originpoly-bio-tec-co

- Industry: Healthcare Specialists
- Headquarters: Beijing, China
- Website: www.cispoly.com
- Total disclosed funding: $30M
- Latest round: Series B (Dec 27, 2023)
- Investors on record: 5

## About

Established in 2020 and based in Beijing, China, Beijing OriginPoly Bio-Tec Co.,LtD. is a biotech company that focuses on early diagnosis of female tumors. The company has 900 square meters of GMP production workshop and 800 square meters of research and development laboratory. Mr. Pei Liu is the founder of the company. In December 2023, the firm raised a series B funding for CNY 100 million.

The company engages in the research and development of early diagnosis products for gynecological tumors. The company's products mainly include early diagnosis products for gynecological tumors such as cervical cancer, ovarian cancer, and endometrial cancer.

## Funding rounds

- Series B, Dec 27, 2023, $14M — Sunland Capital, Prosperity7
- Series A, Apr 22, 2022, $15M — Haibang Venture, Greatwall Fund
- Angel, Oct 1, 2020 — ZhenFund

## Investors

- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Angel
- Haibang Venture — Series A
- Greatwall Fund (https://capitalatlas.ai/funds/greatwall-fund) — Series A
- Sunland Capital — Series B
- Prosperity7 (https://capitalatlas.ai/funds/prosperity7) — Series B